Cargando…
Thrombotic Complications in Children with COVID-19 and MIS-C
Coronavirus disease 2019 (COVID-19) associated coagulopathy is multifactorial and involves inflammation driven hypercoagulability, endothelial dysfunction, platelet activation and impaired fibrinolysis. Hospitalized adults with COVID-19 are at an increased risk of both venous thrombo-embolism (VTE)...
Autores principales: | Kumar, Riten, Rivkin, Michael J., Raffini, Leslie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232718/ https://www.ncbi.nlm.nih.gov/pubmed/37268064 http://dx.doi.org/10.1016/j.jtha.2023.05.020 |
Ejemplares similares
-
Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C
por: Whitworth, Hilary, et al.
Publicado: (2021) -
Thrombotic events in critically ill children with coronavirus disease 2019 or multisystem inflammatory syndrome in children
por: Dain, Aleksandra S., et al.
Publicado: (2022) -
MIS-C is a risk factor for thrombotic events
por: McHugh, Jessica
Publicado: (2021) -
Thromboembolic complications in children with COVID-19 and MIS-C: A narrative review
por: Trapani, Sandra, et al.
Publicado: (2022) -
Evaluation of antithrombotic prophylaxis and thrombotic events in children with COVID-19 or MIS-C: A tertiary pediatric center experience
por: Guner Ozenen, G., et al.
Publicado: (2023)